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Available online 14 June 2007Abstract—The synthesis of a set of new N-heteroaryltetramines is reported. A regioselective alkylation on the N-exo nitrogen of
pyridinium N-(heteroaryl)aminide with the corresponding tetrabromo compounds, followed by a clean N–N bond reduction of
the corresponding tetra-salts, allowed an easy and general method to obtain N,N 0,N00,N000-tetrakis(2-heteroaryl)tetramines.
 2007 Elsevier Ltd. All rights reserved.Biogenic polyamines1 play an important role in various
biological and pathological processes2 and synthetic
analogs oﬀer a wide range of therapeutic potential.3
The biological interest in these compounds has pro-
moted the development of eﬃcient synthetic methods
for polyamine analogs and conjugates4 both in solution
and in the solid phase,5 not only for linear analogs but
also for dendrimer-like polyamines.6 In addition, the
pyridine ring takes part in many biological and chemical
reactions and the pyridine ring itself—particularly amino-
pyridinides—are interesting because of their chelating
abilities, the reason for which they are commonly used
as ligands in inorganic and organometallic chemistry.7
These characteristics are being used to develop new het-
erocyclic multidentate molecules for the use in coordina-
tion chemistry,8 and in recent years many related
references can be found in the literature that describe
2-aminopyridines,9 2-aminoquinolines,10 and 2-amino-
benzothiazoles11 as part of organometallic complexes.
Finally, 2-aminopyridine fragments have been used as
part of an abiotic receptor for the recognition of
monosaccharides.12
The present Letter describes the results obtained in the
synthesis of N,N 0,N00,N000-tetrakis(2-heteroaryl)tetram-
ines 7 and 8 from 1,6-bis[3,5-bis(bromomethyl)phen-
oxy]hexane (2b) or 1,3-bis[3,5-bis(bromomethyl)phen-0040-4039/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetlet.2007.06.044
* Corresponding author. Fax: +34 91 885 46 86; e-mail: julio.
alvarez@uah.esoxymethyl] benzene (3b) and pyridinium N-(2-hetero-
aryl)aminide 4.
The preparation of the chosen tetrabromo compounds
1,6-bis[3,5-bis(bromomethyl)phenoxy]hexane 2b and
1,3-bis[3,5-bis(bromomethyl)phenoxymethyl]benzene 3b
(Scheme 1) was achieved from the corresponding alco-
hols 2a and 3a. The preparation of these alcohols was
carried out as previously described;13 dimethyl 5-
hydroxyisophthalate, obtained by esteriﬁcation of 5-
hydroxyisophthalic acid with methanol, was treated
with the corresponding dibromide in anhydrous DMF
and K2CO3 as a base
14 to give tetraesters 1a, b, which
were then reduced15 using LiAlH4 in THF to give the
desired tetra-alcohols 2a and 3a. The preparation of
1,6-bis[3,5-bis(bromomethyl)phenoxy]hexane 2b was
accomplished from tetraester 1a without the isolation
of 2a, which was transformed into 2b by the addition
of hydrobromic acid in a one-pot process. As expected,
the high C–O lability in benzylic derivative 3a toward
acid media made this simple process unsuitable to pre-
pare 1,3-bis[3,5-bis(bromomethyl)phenoxymethyl]ben-
zene 3b.16 Alternatively, other bromination methods17
were tested on 3a with little or no success. Tetrabromo
compound 3b was ﬁnally obtained in good yield using
a mixture of N-bromosuccinimide (NBS) and triphenyl-
phosphine (Ph3P) in dichloromethane, treated in an
ultrasonic bath for 90 min.18 The use of ultrasound
was essential to keep the alcohol in solution.
Once derivatives 2b and 3b had been prepared, alkyl-
ation with diﬀerent N-pyridinium aminides 4 was tried
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5900 R. Castillo et al. / Tetrahedron Letters 48 (2007) 5899–5903as previously reported,19 and the products 5 and 6 were
only obtained on using DMF as a solvent, where inter-
mediate mono-, di-, and tri-salts were kept in solution
and could react to give the ﬁnal product (Scheme 2). Iso-
lation of 5 and 6 was achieved by concentrating the mix-
ture to a minimum volume of solvent to keep the
products in solution, and subsequently adding the solu-
tion dropwise to vigorously stirred AcOEt. This pro-
duced precipitation of tetra-salts 5 and 6 while the
corresponding N-aminide 4 remained in solution.20
The solid obtained in this way was ﬁltered oﬀ, washed
with AcOEt21 and dried under vacuum to give the de-
sired salt (Scheme 2). Aminides 4a–d were prepared as
described19a,b,22 and 4e was obtained by Suzuki reaction
of pyridinium N-(5-bromopyridin-2-yl)aminide23,19b and
4-hydroxymethylphenylboronic acid.24
Finally, salts 5 and 6 had to be converted into N-hetero-
aryltetramines 7 and 8. In previous papers, conversion
of related N-aminopyridinium salts into 2-aminopyr-Table 1. Comparative chart for reduction of 5a under diﬀerent conditions
Reduction conditions Work up
BEt3 (12 equiv)/MeOH, 30 C, 18 h Extracti
Salt form
Rebasify
BEt3 (12 equiv)/MeOH–10% H2O, 30 C, 18 h
AcOH–MeOH (2:1)/Zn, rt, 12 h Extracti
aMeasured by HPLC/MS.idines was described with diﬀerent reducing agents,
such as Zn/AcOH,19a,b,d Pt/C–Et3N/HCOOH,
19c,e,23 or
BEt3–MeOH.
25 These methods may be applied to tet-
ra-salts with slight modiﬁcations to increase the solubil-
ity of the starting materials, and the results obtained in
the reduction of 5a using three diﬀerent methods are
summarized in Table 1.
Although all experiments gave similar good results (con-
versions between 80% and 90%) the metal–acid system
was chosen due to the ease of processing26 and a series
of N-heteroaryltetramines (Table 2) were successfully
obtained.
In conclusion, a viable strategy for the formation of
N,N 0,N00,N000-tetrakis(2-heteroaryl)tetramines has been
developed and involves the use of a quadruple and regio-
selective alkylation and the selective reduction of an
N–N-bond. Attempts to apply this methodology to ob-
tain central cores in dendrimer synthesis are in progress.conditions Conversiona (%)
on with NaOH (10%) and AcOEt
ation with HCl (10%)
and extract with AcOEt
81
90
on with NaOH (10%) and AcOEt 85
Table 2. Results obtained in the alkylation and reduction reactions. Compounds 5a–c, 6a–c, 7a–c, and 8a–c
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mixture was stirred at room temperature for 12 h. During
this time a color change was observed. The crude mixture
was evaporated to dryness and treated with a mixture of
R. Castillo et al. / Tetrahedron Letters 48 (2007) 5899–5903 5903NaOH (10%) (15 mL) and AcOEt (30 mL). Two layers
were separated and the organic phase was dried over
MgSO4, the solvent was removed in vacuo and the residue
puriﬁed by chromatography through a silica gel column,
using a suitable solvent as the eluent, and ﬁnally recrys-
tallized to give the corresponding tetra-aminopyridine 8
and 9 as a pale yellow solids.
1,6-Bis[3,5-bis(pyridin-2-ylaminomethyl)phenoxy]hexane
(7a): White solid (59 mg, 85%, ethyl acetate); mp: 92–
94 C; IR (KBr): mmax (cm1) 3251, 2924, 1600, 1455, 1328,
1291, 1154, 1049, 979, 845, 771; 1H NMR (300 MHz,
CDCl3): d (ppm) 8.06 (4H, ap dd, J = 5.0 and 1.8 Hz, H6),
7.36 (4H, ddd, J = 8.6, 7.2 and 1.8 Hz, H4), 6.90 (2H, br s,
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(4H, m, CH2c);
13C NMR (75 MHz, CDCl3): d (ppm)
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137.4 (C4), 118.3 (C4Ar), 113.1 (C2Ar(6Ar)), 112.2 (C5),
106.8 (C3), 67.8 (CH2O), 46.3 (CH2N), 29.7 (CH2b), 25.8(CH2c); HRMS (ESI-TOF, CH3OH): [M+H]
+ calcd for
C42H46N8O2, 695.3812; found, 695.3860.
1,3-Bis[3,5-bis(quinolin-2-ylaminomethyl)phenoxymethyl]-
benzene (8b): Yellow solid (81 mg, 89%, ethyl acetate); mp:
133–135 C. IR (KBr): mmax (cm1) 3417, 2925, 1618, 1400,
1290, 1154, 1049, 893, 818, 756, 456. 1H NMR (500 MHz,
(CD3)2CO): d (ppm) 7.81 (4H, d, J = 8.9 Hz, H4), 7.58
(4H, dd, J = 8.0 and 1.5 Hz, H5), 7.55 (4H, dd, J = 8.4
and 1.5 Hz, H8), 7.44 (4H, ddd, J = 8.4, 7.1 and 1.5 Hz,
H6), 7.41 (1H, br s, H2Xyl), 7.26 (3H, m, H4Xyl(6Xyl) and
H5Xyl), 7.13 (4H, ddd, J = 8.0, 6.9 and 1.1 Hz, H7), 7.10
(2H, br s, H4Ar), 6.98 (4H, d, J = 1.3 Hz, H2Ar(6Ar)), 6.81
(4H, d, J = 8.9 Hz, H3), 4.99 (4H, s, CH2O), 4.69 (4H, s,
CH2N).
13C NMR (75 MHz, (CD3)2CO): d (ppm) 159.7
(C1Ar), 157.5 (C2), 148.8 (C8a), 142.7 (C3Ar(5Ar)), 138.3
(C1Xyl(3Xyl)), 137.1 (C4), 129.5 (C7), 129.0 (C5Xyl), 128.0
(C5), 127.5 (C4Xyl(6Xyl)), 127.2 (C2Xyl), 126.7 (C8), 124.1
(C4a), 122.0 (C6), 120.1 (C4Ar), 113.3 (C3), 113.1
(C2Ar(6Ar)), 69.9 (CH2O), 44.9 (CH2N); HRMS (ESI-
TOF, CH3OH): [M+H]
+ calcd for C60H50N8O2, 915.4124;
found, 915.4162.
